Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
1819 |
|
| Actual shortage: | 54 (3%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 13 (1%) | |
| Resolved: | 1751 (96%) | |
Discontinuation Reports |
74 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 71 (96%) | |
| Reversed: | 2 (3%) | |
Late reports |
439 (23%) |
|
Overdue reports |
1 (2%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VISTITAN | 0.03% | SOLUTION | Resolved | 2021-09-13 | 2021-10-04 | 145576 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2022-02-01 | 2022-03-25 | 154002 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2022-06-29 | 2022-07-07 | 163618 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2023-04-11 | 2023-04-22 | 189229 |
| VISTITAN | 0.03% | SOLUTION | Actual shortage | 2024-03-05 | 2024-04-16 | 221377 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2022-11-28 | 2023-01-19 | 175970 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2023-03-03 | 2023-04-22 | 186176 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2023-07-10 | 2023-08-01 | 198005 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2023-11-06 | 2024-01-03 | 209230 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2017-03-14 | 2017-07-05 | 2530 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2017-07-11 | 2017-08-02 | 15469 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2020-10-22 | 2020-11-28 | 126961 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2022-02-08 | 2022-02-25 | 154511 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2022-04-06 | 2022-09-28 | 158050 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2022-11-28 | 2023-01-19 | 176073 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 10G | POWDER FOR SOLUTION | Resolved | 2017-03-14 | 2023-11-17 | 2539 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2017-04-18 | 2017-05-17 | 7168 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2017-07-11 | 2017-10-25 | 15466 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2017-11-29 | 2018-01-08 | 31063 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2017-11-29 | 2018-01-08 | 31066 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 10000UNIT | SOLUTION | Discontinued | 2023-10-18 | 2023-10-19 | 207275 |
| HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) | 10000UNIT | SOLUTION | Discontinued | 2018-07-04 | 2018-07-31 | 54349 |
| FOLIC ACID INJECTION USP | 5MG | LIQUID | To be discontinued | 2019-05-01 | 2019-05-01 | 82956 |
| FOLIC ACID INJECTION USP | 5MG | LIQUID | Discontinued | 2020-01-28 | 2020-01-28 | 104481 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Discontinued | 2018-08-27 | 2019-01-02 | 59179 |
| COMTAN | 200MG | TABLET | Discontinued | 2022-03-03 | 2022-03-04 | 155940 |
| CODEINE PHOSPHATE INJECTION USP | 30MG | LIQUID | Discontinued | 2022-04-20 | 2022-04-20 | 159064 |
| CLINDAMYCIN INJECTION USP | 150MG | LIQUID | Discontinued | 2017-06-06 | 2017-10-18 | 12122 |
| BRETYLIUM TOSYLATE INJECTION USP | 50MG | SOLUTION | Discontinued | 2017-12-06 | 2017-12-06 | 31958 |
| BRETYLIUM TOSYLATE INJECTION USP | Discontinued | 2020-04-01 | 2020-04-01 | 110288 | ||
| BLUE COLLYRIUM | Discontinued | 2019-10-15 | 2019-10-15 | 96619 | ||
| BETAJECT | Discontinued | 2019-10-15 | 2019-10-15 | 96616 | ||
| ATRACURIUM BESYLATE INJECTION | Discontinued | 2019-10-15 | 2019-10-15 | 96613 | ||
| ALFENTANIL INJECTION USP | Discontinued | 2019-10-15 | 2019-10-15 | 96610 |